Introducing SMN lacking exon 7 (SMNΔ7)—the predominant mRNA produced by SMN2—into a severe SMA mouse genetic background partially ameliorates the SMA phenotype and these mice die at 14–15 days13. Here, SMN2 is linked to proximal spinal muscular atrophy.